Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
170
Jazz
77
Análisis de series de tiempo
45
Música popular
43
Civilización
28
Métodos estadísticos
28
Espacio y tiempo
26
Filosofía
23
Historia y crítica
23
Novela inglesa
23
Cosmología
22
Aspectos sociales
21
Biografías
19
Música vocal (Jazz)
19
Modelos matemáticos
18
Administración
17
Blues (Música)
17
Música instrumental
17
Estudio y enseñanza
16
Inglés
16
Tiempo
16
Administración del tiempo
15
Música
14
Antigüedades
13
Ciencia
13
Estudio de tiempos
13
Procesamiento de datos
13
Crítica e interpretación
12
Vida social y costumbres
12
Administración industrial
11
-
1040781por Kariampuzha, William Z., Alyea, Gioconda, Qu, Sue, Sanjak, Jaleal, Mathé, Ewy, Sid, Eric, Chatelaine, Haley, Yadaw, Arjun, Xu, Yanji, Zhu, Qian“…Epidemiologic Information (EI) regarding prevalence and incidence data of rare diseases is sparse and current paradigms of identifying, extracting, and curating EI rely upon time-intensive, error-prone manual processes. With these limitations, a clear understanding of the variation in epidemiology and outcomes for rare disease patients is hampered. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040782por Xiao, Ji, Liu, Ping, Hu, Yuze, Liu, Tao, Guo, Yuying, Sun, Pinghua, Zheng, Junxia, Ren, Zhe, Wang, Yifei“…METHODS: The antiherpes virus activity of Fr.8.3 was mainly characterized by cytopathic effects, real-time PCR detection of viral gene replication and expression levels, western blotting, viral titer determination and plaque reduction experiments. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040783por Wang, Paul J., Lu, Ying, Mahaffey, Kenneth W., Lin, Amy, Morin, Daniel P., Sears, Samuel F., Chung, Mina K., Russo, Andrea M., Lin, Bryant, Piccini, Jonathan, Hills, Mellanie True, Berube, Caroline, Pundi, Krishna, Baykaner, Tina, Garay, Gotzone, Lhamo, Karma, Rice, Eli, Pourshams, Idean A., Shah, Rushil, Newswanger, Paul, DeSutter, Katie, Nunes, Julio Cesar, Albert, Michelle A., Schulman, Kevin A., Heidenreich, Paul A., Bunch, T. Jared, Sanders, Lee M., Turakhia, Mintu, Verghese, Abraham, Stafford, Randall S.“…The treatment effects lessened over time: at 6 months the difference in medians was 4.7 points for Decision Conflict Scale (P=0.060) and 0 points for Decision Regret Scale (P=0.35). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040784“…Post-transformation to FHCs, improved timings, additional human resources, new services, fully functioning laboratories, and well stocked pharmacies were observed and linked to improved service utilization and reduced cost of care. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040785por Tantoso, Erwin, Eisenhaber, Birgit, Sinha, Swati, Jensen, Lars Juhl, Eisenhaber, Frank“…Whereas the literature growth rates were highest for uncharacterized or understudied genes until 2005–2010 compared with other groups of genes, they became negative thereafter. At the same time, literature for anyhow well-studied genes started to grow explosively with threshold T10 (≥ 10 FPEs). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040786“…The mean preoperative UDVA significantly improved from 0.53 ± 0.02 logMAR to 0.07 ± 0.01 logMAR and 0.08 ± 0.01 logMAR at 6 and 12 months, respectively (P < 0.001) while the mean preoperative logMAR CDVA showed non-significant change over time throughout the study (P = 0.135). At the end of the study, 41 eyes (85.4%) achieved UDVA of 20/25 or better and no eye lost any lines of CDVA. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040787por Chiou, Piao-Yi, Tsao, Wei-Wen, Lin, Kuan-Chia, Fang, Yuan-Yuan, Lin, Kuan-Yin, Li, Chia-Lin“…Mobile VCT was provided to participants at an assigned time and place. Demographic characteristics and risk-taking and protective features of the MSM were collected via online questionnaires. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040788por Lipton, Richard B., Pozo-Rosich, Patricia, Blumenfeld, Andrew M., Li, Ye, Severt, Lawrence, Stokes, Jonathan T., Creutz, Lela, Gandhi, Pranav, Dodick, David“…In exploratory analyses, atogepant 30 and 60 mg were associated with nominal improvements in MSQ RFP and EF domains, other AIM-D outcomes, and HIT-6 scores at the earliest time point (week 4) and throughout the 12-week treatment period. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040789por Single, Michael, Bruhin, Lena C, Schütz, Narayan, Naef, Aileen C, Hegi, Heinz, Reuse, Pascal, Schindler, Kaspar A, Krack, Paul, Wiest, Roland, Chan, Andrew, Nef, Tobias, Gerber, Stephan M“…This has become particularly relevant, given the need for real-time sensor data that could help lower health care costs by reducing the frequency of clinical assessments performed by specialists and improve access to health assessments (eg, for people living in remote areas or older adults living at home). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040790por Shi, Yuankai, Qin, Xintian, Peng, Xingchen, Zeng, Aiping, Li, Jingao, Chen, Chuanben, Qiu, Sufang, Pan, Suming, Zheng, Yulong, Cai, Jing, Chen, Xiaopin, Qu, Shenhong, Lin, Lizhu, Huang, Jianli, Wu, Hui, Lu, Ying, Wang, Wei, Hu, Changlu, He, Xia, Yu, Zhonghua, Liu, Xiaojian, Xie, Bo, Liu, Anwen, Hu, Guangyuan, Jing, Shanghua, Zhang, Qingyuan, Guo, Renhua, Li, Qi, Hong, Jinsheng, Jin, Feng, Meng, Juan, Shi, Jianhua, Wang, Peiguo, Cui, Jiuwei, Yang, Kunyu, Zhang, Xuebang, Li, Xiaojiang, Shen, Liangfang, He, Yuxiang, Zhai, Limin, Sun, Xiuhua, Ge, Junyou, Qing, Yan, Zong, Dekang“…As of data cutoff date on Jul 13th, 2021, the median follow-up time was 21.7 months (95%CI 19.8–22.5). For FAS population, the IRC-assessed ORR was 26.5% (95%CI 19.2–34.9%), and disease control rate (DCR) was 56.8% (95%CI 47.9–65.4%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040791por Korde, Neha, Tavitian, Elizabet, Mastey, Donna, Lengfellner, Joseph, Hevroni, Gil, Zarski, Andrew, Salcedo, Meghan, Mailankody, Sham, Hassoun, Hani, Smith, Eric L., Hultcrantz, Malin, Shah, Urvi, Tan, Carlyn, Diamond, Benjamin, Shah, Gunjan, Scordo, Michael, Lahoud, Oscar, Chung, David J., Landau, Heather, Giralt, Sergio, Derkach, Andriy, Atkinson, Thomas M., Sabbatini, Paul, König, Francesca, Usmani, Saad Z., Landgren, Ola, Lesokhin, Alexander M.“…Associations between physical activity measurements, QLQC30 and MY20 scores, and time from the start of treatment were estimated using a linear mixed model with a random intercept. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040792por Zhao, Zhirong, Luo, Qiang, Liu, Yi, Jiang, Kexin, Zhou, Lichen, Dai, Ruiwu, Wang, Han“…Finally, quantitative real-time polymerase chain reaction (qPCR) was used to detect the changes in non-coding RNAs and key mRNAs in the pancreatic tissues of patients with CP and PDAC. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040793por Ghassab-Abdollahi, Nafiseh, Nadrian, Haidar, Pishbin, Kobra, Shirzadi, Shayesteh, Sarbakhsh, Parvin, Saadati, Fatemeh, Moradi, Mohammad Sanyar, Azar, Pouria Sefidmooye, Zhianfar, Leila“…Future actions should be focused on appropriate timely action plans for the prevention and control of T2DM from early years of life.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040794por Ramalingam, Karthikeyan, Krishnan, Murugesan, Ramani, Pratibha, Muthukrishnan, Arvind“…We observed that the average rating of overall health and overall QOL at the time of diagnosis was 5.4. After one year of follow-up, the average rating of overall health and overall QOL was found to be 3.4. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040795por Lee, Zheng-Yii, Ortiz-Reyes, Luis, Lew, Charles Chin Han, Hasan, M. Shahnaz, Ke, Lu, Patel, Jayshil J., Stoppe, Christian, Heyland, Daren K.“…Given the low certainty of evidence, this potentially life-saving therapy warrants further studies to identify the optimal timing, dosage, treatment duration, and patient population that will benefit most from IVVC monotherapy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040796“…RESULT(S): PAR2 activation by 2fLI promoted wound healing compared to 2fO or vehicle control at the 24-hr time point (p<0.05). PAR2 activation had no effect on proliferation at the wound edge and did not affect apoptosis but did enhance lamellipodia/filopodia formation (p<0.001). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040797por Olivera, P, Martinez-Lozano, H, Leibovitzh, H, Xue, M, Xu, W, Espin-Garcia, O, Madsen, K, Meddings, J, Guttman, D, Griffiths, A, Huynh, H, Turner, D, Panancionne, R, Steinhart, H, Aumais, G, Jacobson, K, Mack, D, Marshall, J, Moayyedi, P, Lee, S -H, Turpin, W, Croitoru, K“…A Cox proportional hazards model was used to assess time-related risk of future onset of CD. RESULT(S): 4385 subjects were included. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040798“…This responsibility was often deferred to the dietitian, thereby minimizing the role that physicians play or believe they have in its management. A lack of time during clinical encounters was also a key contributing factor. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040799“…PURPOSE: We aim to evaluate the pattern of PBE of CD patients at time of diagnosis (prior to drug exposure) and with each subsequent treatment; and if baseline PBE or any changes seen with drug exposures are predictive of treatment response. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1040800“…Mean age at diagnosis was 13.2 years (IQR = 11.20 to 15. 20). Median time to IFX initiation after diagnosis was 5 days (IQR :3-14).Median IFX dose #1: was 8.4 mg/kg (IQR = 5. 8 to 10). 90% of patient had an IFX optimisation (increasing dose and/or shortening intervals) after dose 3 or dose 4. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto